Classification Term: 903
Phenylimidazolidines (ontology term: CHEMONTID:0002547)
Polycyclic compounds containing an imidazoline substituted by a phenyl group." []
found 7 associated metabolites at category metabolite taxonomy ontology rank level.
Ancestor: Imidazolidines
Child Taxonomies: There is no child term of current ontology term.
4-(1,3-Dihydroxy-4,4,5,5-tetramethyl-imidazolidin-2-yl)benzoic acid
4-(1,3-dihydroxy-4,4,5,5-tetramethylimidazolidin-2-yl)benzoic acid
2-Imidazolidinone, 1-(3,5-dichlorophenyl)-3-(2-(1,4-dioxa-8-azaspiro(4.5)dec-8-yl)ethyl)-
1-(3,5-dichlorophenyl)-3-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}ethyl)imidazolidin-2-one
ARN-509
4-{7-[6-cyano-5-(trifluoromethyl)pyridin-3-yl]-8-oxo-6-sulphanylidene-5,7-diazaspiro[3.4]octan-5-yl}-2-fluoro-N-methylbenzene-1-carboximidic acid
Enzalutamide
4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl}-2-fluoro-N-methylbenzamide
L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BB - Anti-androgens C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
N-desmethyl enzalutamide
4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl}-2-fluorobenzamide
